Jack Lewin, MD is President and Chief Executive Officer. Dr. Lewin served as CEO of the American College of Cardiology (ACC) from 2006 through April 2012. The 41,000 member ACC represents over 90% of U.S. cardiologists, 5,000 cardiovascular nurses and clinicians and over 5,000 international members. Prior to his stint at ACC, Lewin was CEO of the 35,000 member California Medical Association for eight years. Previously, he was Hawaii's Director of Health from 1986-1994, overseeing 6,500 employees, 12 hospitals, and a billion-dollar budget. Before that, as a Commissioned Officer in the US Public Health Service, Dr. Lewin was the founder and first Director of the Navajo Nation Department of Health, serving the needs of America's largest American Indian tribe. He currently serves as the voluntary Chairman of the Board for the National Coalition on Health Care. In 2011, he was named as one of Modern Healthcare's 100 Most Influential People in Healthcare. Dr. Lewin received his BA in Biological Sciences from the University of California, Irvine, and his MD from the University of Southern California. Jack may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Gary S. Mintz, MD, Chief Medical Officer, is a renowned expert in the area of cardiovascular imaging and has extensive experience in both interventional cardiology and cardiac ultrasound. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program, which has studied over 30,000 patients using intravascular ultrasound and has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis. Gary may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Andrew F. Kraus, Chief Operating Officer and Treasurer, oversees Finance, Information Technologies, operational and corporate digital strategies, technology infrastructure for the CRF Skirball Center for Innovation, CRF Clinical Trials Center, and CRF Center for Education. A successful entrepreneur and seasoned executive with over 21 years of experience in the clinical trial industry, Andrew has led business operations through the development and implementation of advanced technology solutions. Prior to CRF, Andrew served as Executive VP, Global Data Technologies at ICON, plc. Before joining ICON, Andrew founded his first company in 1998, and in 2001 was Co-Founder and served on the Board of Directors of Beacon Bioscience, a medical imaging core laboratory. Andrew received his Bachelor’s and Master’s degrees in Bioengineering from the University of Pennsylvania with a focus on neural networks in medical image analysis. Andrew may be reached at This email address is being protected from spambots. You need JavaScript enabled to view it..

Donald L. Abrams, Esq, General Counsel, has worked at CRF since August 2000. Prior to this, he served as Corporate Counsel at Columbia Cornell Care. Don may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Eileen Morales, Controller, came to CRF in January 2001. She had previously been in the accounting office of a law firm in New York. Eileen may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Ori Ben-Yehuda, MD, Executive Director of the CRF Clinical Trials Center (CTC), oversees all CTC activities. Dr. Ben-Yehuda is a distinguished clinical cardiologist and co-author of numerous scientific publications in top tier medical journals. Most recently, Dr. Ben-Yehuda was Vice President, Cardiovascular Clinical Research at Gilead Sciences. Prior to that, he was Professor of Clinical Medicine at the University of California, San Diego (UCSD) and the Director of the Coronary Care Unit at UCSD Medical Center. Dr. Ben-Yehuda also served as the Deputy Editor of the Journal of the American College of Cardiology. Ori can be reached at This email address is being protected from spambots. You need JavaScript enabled to view it..

Juan F. Granada, MD, Executive Director and Chief Scientific Officer of the CRF Skirball Center for Innovation. Prior to joining CRF, Dr. Granada served as Director of Cardiovascular Translational Research at the Methodist DeBakey Heart Center, in Houston, Texas. Juan may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Joshua D. Hartman, MBA, Executive Director, CRF Center for Education (CED), joined CRF in May 2007. Prior to becoming Executive Director of the CED, he was Director, Educational Services & Strategic Relations and Managing Editor of TCTMD. Previously, Josh served as the Director of Online Marketing and Education at PPD, Inc. and Clinsights, Inc., and before that, a Senior Consultant in the Integrated Health Group at Deloitte Consulting. He helped found and develop the TCTMD web site in April 2000. Josh may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Philippe Généreux, MD, is Director, Angiographic Core Laboratory at CRF. He also serves as an Interventional Cardiologist at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Hôpital du Sacré-Coeur de Montréal. He received his medical degree from the Université de Montréal, Québec, Canada and is currently pursuing a PhD at Erasmus University in Rotterdam, The Netherlands. Philippe may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Alejandra Guerchicoff, PhD, Co-Director, Event Adjudication and Reporting at the CRF Clinical Trials Center. Dr Guerchicoff devoted her basic and clinical research efforts to studying the genetic basis and molecular mechanisms of heart disease. Dr Guerchicoff is a member of the faculty at Mount Sinai School of Medicine and the Laboratory Director for the New York University Cardiogenomics Program and for the Molecular Genetic Program at the Masonic Medical Research Laboratory. Alejandra may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Greg L. Kaluza, MD, PhD, Director of Research of the CRF Skirball Center for Innovation. Prior to joining CRF, Dr. Kaluza served as Scientific Director of the Center for Research in Cardiovascular Interventions and as Co-Director of the Core Angiographic Laboratory at the Methodist Hospital Research Institute in Houston, Texas. Greg may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Ioanna Kosmidou, MD, PhD, is Director of Safety at the CRF Clinical Trials Center. A board certified cardiologist and electrophysiologist, Dr. Kosmidou joined CRF in 2015 as Associate Director, Clinical Development. She completed her residency in internal medicine at Tufts University/St. Elizabeth’s Medical Center and her cardiology fellowship at Emory University in Atlanta, followed by subspecialty fellowship in electrophysiology at the Brigham and Women’s Hospital in Boston. Dr. Kosmidou received her medical degree from the University of Patras and PhD from Athens University, both in Greece. Ioanna can be reached at This email address is being protected from spambots. You need JavaScript enabled to view it..

Hugh J. Linnehan, JD, Director of Operations at the CRF Skirball Center for Innovation. Hugh has held leadership positions in the non-profit and business sectors, and most recently served as Executive Director of RHD International, a non-profit organization focusing on the prevention and control of rheumatic heart disease. Hugh may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Melissa Nichols, Director, Data Coordinating Center, oversees the Biostatistics, Programming, and Data Management at the CRF Clinical Trials Center. Prior to joining CRF, Melissa worked as a consultant for Cytel Inc., Ironwood Pharmaceuticals, and Genzyme Corporation. She also previously served as Associate Director for Biostatistics at Infinity Pharmaceuticals, and a Principal Biostatistician for CominatoRx , Synta Pharmaceuticals, and Genyzme. Melissa is a graduate of the State University of New York at Albany with a Bachelor of Arts in Statistics and a Master of Sciences in Biostatistics. Melissa can be reached at This email address is being protected from spambots. You need JavaScript enabled to view it.

Kelli O'Toole, PHR, Director of Human Resources and Office Services, joined CRF in 2001. Prior to that, she worked in Human Resources at another non-profit organization in New York. Kelli may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Tricia Rawh, Director, Industry Relations, is responsible for all relationships with industry for the Center for Education. She oversees grant acquisition, promotional sponsorships, exhibits, and satellite symposia. Tricia joined CRF in June 2008 as a Project Manager in the Creative and Marketing Services department before transitioning over to a program project management role in the Educational Services & Strategic Relations department. Prior to joining CRF, she was an Account Manager at Thomas Publishing Company LLC. Tricia may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Colleen Whelan, Director, CME and Program Development, joined CRF in May 2000 in Academic Coordination. Prior to that, she was a Research Assistant in the Cath Lab at Cornell Medical College. Colleen can be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

Valerie Wilkins, Director, Quality Assurance, joined CRF in January 2015. An experienced global compliance professional, Valerie was previously Compliance Senior Manager at Amgen, and prior to that was the Associate Director, Clinical Quality Assurance at Novartis. She has held numerous roles at Johnson & Johnson, Hoffmann La Roche/Genentech, Schering Plough, and Mylan Pharmaceuticals. She is also Certified Clinical Research Associate, a Registered Quality Assurance Professional, and Certified Lead QMS Auditor for ISO9001. Valerie may be contacted at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

  • TVT
    Transcatheter Valve Therapies (TVT) 2015
    June 4-6, 2015
    Hilton Chicago Hotel
    720 S Michigan Ave
    Chicago, IL

    Expanding Your Practice to Include Complex and Higher-Risk Indicated Patients (CHIP)
    August 6-7, 2015
    Grand Hyatt Seattle
    721 Pine Street
    Seattle, WA

    TCT
    Transcatheter Cardiovascular Therapeutics (TCT) 2015
    October 11-15, 2015
    The Moscone Center
    San Francisco, CA

    Pulse
    Pulse of the City Gala
    December 11, 2015
    The Plaza
    New York City, NY

    TCT
    Transcatheter Cardiovascular Therapeutics (TCT) 2016
    October 29-November 2, 2016
    Walter E. Washington Convention Center
    Washington, DC

    TCT
    Transcatheter Cardiovascular Therapeutics (TCT) 2017
    October 22-26, 2017
    The Moscone Center
    San Francisco, CA

    TCT
    Transcatheter Cardiovascular Therapeutics (TCT) 2018
    September 21-25, 2018
    San Diego Convention Center
    San Diego, CA

  • TCT Russia
    June 18-20, 2015
    Moscow, Russia

    SOLACI in Partnership with TCT
    Sociedad Latinoamericana de Cardiología Intervencionista
    August 5-7, 2015
    Mexico City, Mexico

    TCT India
    Advanced Cardiovascular Solutions
    August 14-16, 2015
    Hyderabad, India

    CACI (TCT Highlights Session)
    October 2015
    Buenos Aires, Argentina

    GISE (TCT Highlights Session)
    October 2015
    Genoa, Italy

    ICI
    Innovations in Cardiovascular Interventional Cardiology
    December 2015
    Tel-Aviv, Israel